APEX Harmony Lodge
Singapore, 518240
NCT Number: NCT06880237
This study intends to investigate whether a singing programme for nursing home residents living with dementia can reduce the mental and physiological effects of dementia. The main questions it aims to answer are:
1. Does participating in the Sing Out Loud (SOL) singing intervention lead to an improvement in the physiological well-being (increase in oxytocin and reduction in cortisol levels) of persons living with dementia (PWDs) in nursing homes? 2. Will participation in the SOL singing intervention result in an improvement in PWDs' overall mood, temperament, and mental health (indicated by symptoms such as apathy, aggression, and depression).
Researchers will compare the singing group to the control group to see if they exhibit reduced levels of apathy, aggression, and depression, and whether their levels of oxytocin and cortisol (collected via salivary biomarkers) have increased and decreased, respectively.
Researchers will compare the SOL singing intervention with a waitlist control group to see if the SOL singing intervention increases the feelings of social connection, reduces stress, or improves the symptoms of dementia in nursing home residents.
Participants will be randomly assigned to a singing intervention or waitlist control group. The intervention involves an 8-week long singing programme with one practice session a week, culminating in an additional full dress rehearsal and private showcase performance for their family members at a concert venue.
Looking for future studies?
Notify Me21 year–90 year
All sexes
Interventional
Not applicable
Singapore, 518240
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for Patients:
Exclusion criteria
for Patients:
Inclusion criteria
for Psychologists:
Exclusion criteria
for the Psychologists:
The programme consists of one 75-min-long group singing session per week for 8 weeks, followed by a dress rehearsal and a final performance. The final rehearsal session and showcase performance will be held at a concert venue, while the 8 practice sessions will be conducted at the nursing home.
Each session will kick off with a "Hello song", followed by warm-up activities and vocal exercises. Participants will then sing different songs to explore and rehearse as a group, before concluding with a "Goodbye song". All sessions throughout the programme are similarly structured to provide consistency for participants.
Time frame: From the beginning of the intervention (session 1) on week 1, to the final practice session (session 8) on week 8
Oxytocin and Cortisol levels will be collected via saliva samples. Increases in level of Oxytocin is indicative of increased feelings of social connection, while increased level of Cortisol is indicative of higher levels of stress
Time frame: From 2 weeks before session 1, up to the final practice session (session 8)
Neuropsychiatric symptoms will be collected via the Neuropsychiatric Inventory Questionnaire (NPI-Q), which measures delusions, hallucinations, agitation/aggression, depression/dysphoria, anxiety, elation/euphoria, apathy/indifference, disinhibition, irritability, motor disturbance, nightime behaviours, and appetite. Higher scores indicate increased levels of severity or distress related to the symptom in question.
Time frame: Within two weeks after the programme has ended
This will be collected via a focus group discussion with the nursing home's clinical staff (psychosocial team) to collect qualitative data on any observed changes in participants' mood, behaviour, temperament, or relationships between participants and staff. Additionally, the nursing home's psychosocial team will also be asked about process factors (challenges in implementation, structure and delivery of the programme), satisfaction,
National University of Singapore
Other
Acronym: SOL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06347172
Alzheimer Disease, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT07306065
Alzheimer Disease, Alzheimers Disease
Orlando, Florida, United States
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT05529706
Alzheimer Disease, Brain Diseases
San Francisco, California, United States
View Trial Details